COG7 Antibodies

Santa Cruz Biotechnology provides a broad selection of COG7 monoclonal antibodies for research focused on understanding COG7 protein functions. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). COG7, or Component of Oligomeric Golgi Complex 7, is essential for maintaining Golgi structure and function, playing a critical role in protein glycosylation and trafficking. Research has shown that COG7 mutations can lead to various diseases, including congenital disorders of glycosylation. Understanding COG7's cellular functions is crucial for developing new therapeutic approaches. Recent studies have revealed COG7's involvement in maintaining cellular homeostasis and protein transport mechanisms. Ongoing research continues to uncover new aspects of COG7's role in cellular processes. Scientists worldwide are investigating COG7's potential as a therapeutic target for various disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of COG7 and its impact on human health.